Senores Pharmaceuticals IPO is a book-built issue worth ₹582.11 crores. The issue consists of a fresh issue of 1.28 crore shares, aggregating to ₹500.00 crores, and an offer for sale of 0.21 crore shares, aggregating to ₹82.11 crores.
The bidding for the Senores Pharmaceuticals IPO opened on December 20, 2024, and will close on December 24, 2024. The allotment of shares is expected to be finalized on Thursday, December 26, 2024. The IPO is set to list on the BSE and NSE, with a tentative listing date scheduled for Monday, December 30, 2024.
Senores Pharmaceuticals operates in the pharmaceutical sector, specifically focusing on the development and manufacturing of complex generics. They produce a wide range of pharmaceutical products, including antibiotics, anti-bacterial, anti-fungal, and blood line medications. Their products are certified by global regulatory authorities and are distributed in over 49 countries.
The price band for Senores Pharmaceuticals IPO is set between ₹372 and ₹391 per share. Investors must apply for a minimum lot size of 38 shares, requiring a minimum investment of ₹14,858 for retail investors. Small Non-Institutional Investors (sNII) need to invest in at least 14 lots (532 shares), amounting to ₹2,08,012. For Big Non-Institutional Investors (bNII), the minimum investment is 68 lots (2,584 shares), totaling ₹10,10,344.
Equirus Capital Private Limited, Ambit Private Limited, and Nuvama Wealth Management Limited are the book-running lead managers for this IPO, while Link Intime India Private Ltd serves as the registrar.
Senores Pharmaceuticals IPO Details:
| Company Name | Senores Pharmaceuticals Limited |
| Sector | Pharmaceutical |
| IPO Type | Mainboard |
| IPO Open date | 20th Dec 2024 |
| IPO Close date | 24th Dec 2024 |
| OFS | |
| Listing Exchanges | NSE, BSE |
| Share Holding Pre-issue | |
| DRHP Draft Prospectus | Click to check |
| RHP Draft Prospects | Click to check |
Senores Pharmaceuticals IPO Lot Size:
| Application | Lot Size | Shares | Amount |
| Retail (Min) | 1 | 38 | 14,858 |
| sHNI (Min) | 14 | 532 | 2,08,012 |
| bHNI (Min) | 68 | 2584 | 10,10,344 |
Senores Pharmaceuticals IPO Timeline:
| IPO Open Date | 20th Dec 2024 |
| IPO Close Date | 24th Dec 2024 |
| Basis of Allotment | 26th Dec 2024 |
| Refund Initiation Date | 27th Dec 2024 |
| Shares Credit to Demat | 27th Dec 2024 |
| Listing Date | 30th Dec 2024 |
Things to Consider before applying for an IPO
Financial Performance: Review Senores Pharmaceuticals’ Financials to understand its revenue, profitability, and growth prospects.
Industry Outlook: Consider the overall health of India’s Pharmaceutical Industry.
Valuation: Compare the price band to similar companies in the industry to see if the IPO is priced fairly.
Management Team: Research the experience and capabilities of the management team.
Our Verdict
This IPO offers a good opportunity to invest in Senores Pharmaceuticals and be a part of its growth.
FAQ
What is Grey Market Premium (GMP)?
The Grey Market Premium (GMP) represents the price at which an Initial Public Offering (IPO) is traded in the unregulated grey market before its official listing. It serves as an indicator of how the IPO might perform on the listing day. Seeing the latest GMP, investors can estimate the listing performance of the IPO.
